Zenflow spring system for benign prostatic hyperplasia - 24 month outcomes of the ZEST pilot studies
Benign Prostatic Hyperplasia (BPH) affects more than half of men over age 50, yet current treatment options are limited to medications that cause bothersome side effects or surgical procedures, ...
Data Presented at the AUA Meeting Reflect Longest-Term Data among FIT Interventions Reno, Nevada (UroToday.com) -- Zenflow, Inc. announced the results of long-term data demonstrating that the ...
The Zenflow Spring Implant offers a reversible, durable BPH treatment, preserving natural anatomy with a spring-like implant. The BREEZE study showed a 60% responder rate and 37% IPSS improvement, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results